
News|Articles|December 9, 2003
ALLHAT and JNC 7: Health-system applications and economic considerations
New Orleans-The results of the Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack (ALLHAT) Trial, along with the highlights of theSeventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure (JNC 7), were presentedon Dec. 9 at an educational session of the 38th ASHP Midyear Clinical Meeting.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
3 things to know about CVS Health’s 2025 earnings
2
Women show greater dementia risk reduction from shingles vaccine
3
GLP-1 drugs improve health while changing the way cosmetic providers care for patients
4
Aetna Medicaid and NACHC team up to tackle hypertension
5























